Age
Item
1. subject is at least 18 years old.
boolean
C0001779 (UMLS CUI [1])
Compliance behavior Follow-up Evaluation | Telephone Contact
Item
2. subject is willing to comply with pre-specified follow-up evaluation and can be contacted by telephone.
boolean
C1321605 (UMLS CUI [1,1])
C3274571 (UMLS CUI [1,2])
C1261322 (UMLS CUI [1,3])
C0039457 (UMLS CUI [2,1])
C3812666 (UMLS CUI [2,2])
Clopidogrel Dose | Aspirin Dose
Item
3. use of clopidogrel (>=75mg) and aspirin(>=75mg) for at least 1 month.
boolean
C0070166 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0004057 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
Proton pump inhibitor allergy | H2 receptor antagonist allergy
Item
1. known allergy to ppi of h2 blockers
boolean
C0570578 (UMLS CUI [1])
C0570573 (UMLS CUI [2])
Thrombocytopenia | Thrombocytopathy
Item
2. known thrombocytopenia or thrombocytopathia
boolean
C0040034 (UMLS CUI [1])
C0005818 (UMLS CUI [2])
Study Subject Participation Status | Investigational New Drugs | Biological agents Investigational | Investigational Medical Device
Item
3. subject is currently enrolled in another investigational study of a new drug, biologic or device at the time of study screening. note: subjects who are participating in the long term follow-up phase of a previously investigational and now fda-approved product are not excluded by this criterion.
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0005515 (UMLS CUI [3,1])
C1517586 (UMLS CUI [3,2])
C2346570 (UMLS CUI [4])
Heart failure Symptomatic | Left ventricular ejection fraction
Item
4. subject with symptomatic heart failure of lvef ≤ 25%
boolean
C0018801 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2])
Myocardial Infarction
Item
5. acute myocardial infarction within the past 30 days.
boolean
C0027051 (UMLS CUI [1])
Event inflammatory | Communicable Disease | Autoimmune Disease | Event Coronary
Item
6. no acute inflammatory event during the past month (e.g. infection, autoimmune or acute coronary event)
boolean
C0441471 (UMLS CUI [1,1])
C0333348 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2])
C0004364 (UMLS CUI [3])
C0441471 (UMLS CUI [4,1])
C1522318 (UMLS CUI [4,2])
Comorbidity | Life Expectancy
Item
7. concurrent medical condition with a life expectancy of less than 12 months.
boolean
C0009488 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
Kidney Failure Severe | Creatinine measurement, serum
Item
8. known severe renal failure (serum creatinine level >2.5 mg/dl).
boolean
C0035078 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0201976 (UMLS CUI [2])
Bleeding tendency | Blood Coagulation Disorders | Blood Transfusion Receive Unable | Blood Transfusion Receive Unwilling
Item
9. history of bleeding diathesis or coagulopathy or inability or unwillingness to receive blood transfusions.
boolean
C1458140 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
C0005841 (UMLS CUI [3,1])
C1514756 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
C0005841 (UMLS CUI [4,1])
C1514756 (UMLS CUI [4,2])
C0558080 (UMLS CUI [4,3])
Gastrointestinal Hemorrhage | Hemorrhage untreated | Hemorrhage Resolution Lacking
Item
10. evidence of active gastrointestinal bleeding or a history of such bleeding that is not known to have been treated and proven to have resolved.
boolean
C0017181 (UMLS CUI [1])
C0019080 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C0019080 (UMLS CUI [3,1])
C1514893 (UMLS CUI [3,2])
C0332268 (UMLS CUI [3,3])
Hepatitis | Viral hepatitis | Ischemic hepatitis | Hepatitis chemically induced | Icterus | Liver Cirrhosis
Item
11. history of hepatitis (viral, ischemic or chemically-induced); clinical jaundice, history of cirrhosis.
boolean
C0019158 (UMLS CUI [1])
C0042721 (UMLS CUI [2])
C0473117 (UMLS CUI [3])
C0019158 (UMLS CUI [4,1])
C0007994 (UMLS CUI [4,2])
C0022346 (UMLS CUI [5])
C0023890 (UMLS CUI [6])
Anticoagulant therapy | Coumadin | Heparin, Low-Molecular-Weight
Item
12. patient treated with anticoagulant medication (coumadin, lmwh)
boolean
C0150457 (UMLS CUI [1])
C0699129 (UMLS CUI [2])
C0019139 (UMLS CUI [3])